• Maraviroc Workflows for CCR5 Research

  2026-08-25

  Maraviroc, also known as UK-427857, supports precise CCR5 perturbation across HIV-1 entry inhibition, HIV tropism studies, and inflammatory cell models. This workflow-oriented guide translates a recent extracellular-vesicle rheumatoid arthritis study into practical assay design, dosing, controls, and troubleshooting decisions.

• Edible Bird’s Nest Peptide and Skin Repair

  2026-08-25

  The reference study identifies edible bird’s nest peptide as a bioactive hydrolysate with EGF-associated, extracellular-matrix, and anti-inflammatory effects in cell and zebrafish wound-healing models. Its main contribution is integrating tissue-repair, ECM gene-expression, oxidative-stress, cytokine, and neutrophil findings to explain how the peptide may support regeneration, while its preclinical design still limits direct translation to human skin therapies.

• GANT61 Targets Hh–PIK3IP1–Akt in ALK+ ALCL

  2026-08-24

  The 2026 Annals of Hematology study identifies a potential connection between Gli1 inhibition, PIK3IP1 restoration, and attenuation of Akt signaling in ALK-positive anaplastic large cell lymphoma. Its integrated use of proliferation, flow cytometry, transcriptomic, and molecular assays supports a mechanistic model in which GANT61 suppresses lymphoma growth through cell-cycle arrest and apoptosis, while also highlighting important limits of pharmacologic and in-vitro evidence.

• Sumatriptan Metabolism Revisited: CYP and MAO Roles

  2026-08-24

  The reference study challenges the conventional view that sumatriptan is metabolized mainly through monoamine oxidase A, showing that selected cytochrome P450 isoforms also generate N-desmethyl and N,N-didesmethyl metabolites. Its enzyme-resolved HPLC-MS strategy provides a useful framework for distinguishing parallel N-demethylation and oxidative deamination pathways in drug metabolism studies.

• NADH: A Translational Redox Control Point

  2026-08-23

  NADH is more than an energy-metabolism reagent: it is a controllable readout and mechanistic lever linking redox balance, mitochondrial respiration, SIRT1 activity, HIF-1α signaling, and oxidative stress. This thought-leadership guide uses catalpol protection against triptolide-induced liver injury as a translational case study, then outlines how researchers can position NADH measurements and interventions within disease models without overstating the evidence.

• α2-Adrenergic Receptor Agonist Workflow

  2026-08-22

  Build reproducible α2-AR signaling assays with a DMSO-soluble research agonist suited to receptor, immune co-culture, and formulation workflows. The approach separates direct osteosarcoma-cell effects from immune-mediated responses while translating a recent hydrogel study into practical bench decisions.

• One-step TUNEL Cy3 Apoptosis Detection Kit Guide

  2026-08-22

  Learn how to apply the One-step TUNEL Cy3 Apoptosis Detection Kit to DNA fragmentation analysis in tissue sections, adherent cells, suspension cells, and flow-cytometry workflows. The guide connects practical assay design with glioblastoma apoptosis research, including controls, imaging choices, and troubleshooting strategies.

• ETS1–SENP2–HSPA8 Controls Mitophagy in BPD

  2026-08-21

  The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation of FUNDC1 and HSPA8-mediated degradation. Its findings connect transcriptional control, mitochondrial quality control, and chaperone-linked autophagy, while providing a mechanistic framework for interpreting autophagy pathway modulation in lung injury models.

• Dehydroabietic Acid in Ferroptosis-Aware Metabolism

  2026-08-20

  Dehydroabietic acid is a dual PPAR-α/γ agonist with potential value in metabolic disorder research. This article presents a ferroptosis-aware assay framework that separates receptor-driven lipid remodeling from glutamine-dependent antioxidant defenses in hepatocellular carcinoma models.

• EZ Cap™ Cas9 mRNA (5-moUTP) Gene Editing Workflows

  2026-08-20

  Use transient Cas9 delivery to test Fyn–Stat3 mechanisms, optimize zebrafish neurodegeneration models, and build controlled functional gene studies. This workflow combines capped, modified mRNA handling with orthogonal editing, imaging, and inflammatory readouts rather than relying on phenotype alone.

• I-BET151 Workflows for Cancer Biology

  2026-08-19

  Use I-BET151 (GSK1210151A) to connect BET-dependent transcription with enhancer activity, cell fate, and stress responses. This workflow translates the SE/FOXA1/SLC7A11 findings in prostate cancer into practical chromatin, viability, apoptosis, and cell-cycle experiments while clearly separating established evidence from testable extensions.

• Cabozantinib in RCC: Workflow and Adaptation Insights

  2026-08-19

  Build sharper RCC experiments by separating acute kinase suppression from chronic phosphoproteomic adaptation. This workflow connects Cabozantinib exposure, motility assays, endothelial biology, and troubleshooting decisions without confusing biochemical potency with cellular response.

• Hydroxytyrosol Workflows for Cardiovascular Research

  2026-08-18

  Build reproducible cell-based assays around Hydroxytyrosol to connect oxidative stress modulation with inflammatory phenotype and cholesterol efflux. The workflow distinguishes isolated-compound effects from olive oil extracts while providing practical dosing, solvent-control, and troubleshooting guidance.

• Fucoidan C4038: Reliable Cell Assay Workflows

  2026-08-18

  Learn how Fucoidan (SKU C4038) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing assay interference with biological response. This scenario-based guide covers solubility, controls, optimization, interpretation, and practical supplier selection.

• NET-DNA, CCDC25, and ILC3 Repair in Ulcerative Colitis

  2026-08-17

  This FASEB Journal study identifies a mechanistic pathway in which neutrophil extracellular trap DNA suppresses IL-22 production by intestinal ILC3s through CCDC25 and downstream ILK–HIF-1α signaling. The findings connect excessive NET formation with impaired epithelial repair and provide a framework for evaluating mucosal-barrier readouts in ulcerative colitis models.

7686 records 1/513 page Next 12345 下5页 Last page